Generalised myasthenia gravis - treatment refractory initial authority application form (PB396)

Use this form to apply for initial PBS-subsidised treatment with ravulizumab for treatment refractory generalised myasthenia gravis.

Page last updated: 1 March 2026.
QC 83707